Harlan Robins

Harlan Robins, Chief Scientific Officer at Adaptive Biotechnologies (NASDAQ:ADPT), made a large buy and sell of company shares on October 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Harlan Robins exercised options to...

Harlan Robins, Chief Scientific Officer at Adaptive Biotechnologies (NASDAQ:ADPT), made a large buy and sell of company shares on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 15, Harlan Robins...